Whether you are a victim of eye damage caused by Elmiron, or you are wondering if you are eligible for a Class Action lawsuit, there are several things to know before you make a decision.

Settlements based on vision loss

Several thousand individuals are reportedly coming forward with claims that Elmiron caused vision damage. The manufacturers of this drug are being held legally accountable for these hidden problems. They are also required by law to warn the public of the risks.

The jury is still out on how much compensation will be awarded in Elmiron eye damage lawsuits. However, past mass tort cases have paid out substantial compensations. The best place to find out how big a payout you could receive is by contacting a qualified product liability attorney.

The number of new Elmiron Eye Damage Lawsuit has increased dramatically in the past few months. This may be a sign of awareness among consumers. A few months ago, a judicial MDL panel consolidated all Elmiron lawsuits into a single U.S. District Court in New Jersey.

The first test trial is expected to occur in January of 2023. This will give parties an idea of how the case is likely to play out. Afterward, the MDL will move toward a global settlement.

Class action lawsuits filed in New Jersey

Currently, there are almost 800 Elmiron eye damage class action lawsuits pending in a multi-district litigation (MDL) in the United States District Court for the District of New Jersey. These cases were filed by plaintiffs with vision loss, adverse side effects, or other complications resulting from the use of the drug. The plaintiffs claim that the manufacturers did not warn them of the dangers.

According to the complaint, Janssen Pharmaceuticals knew that there were risks associated with Elmiron. However, they concealed that information from patients and physicians. In fact, the company did not put a warning label on the medication until 2020.

Elmiron is a medication that has been approved by the FDA to treat interstitial cystitis, which is a condition that causes the bladder to hold urine after the kidneys filter it. Its active ingredient is pentosan polysulfate sodium, also known as PPS. In clinical trials, researchers found that people who take Elmiron have a higher risk of developing maculopathy, which is a disease of the center of the eye. It is characterized by blurred vision and spots in the eye.

Retinal maculopathy

Several eye conditions have been linked to Elmiron, a drug used to treat interstitial cystitis. Those who take the drug may develop pigmented deposits in their macula, a region of the eye that controls vision. These deposits can cause severe vision loss.

According to a report from Kaiser Permanente, patients who take high doses of Elmiron are more likely to develop retinal damage. These high dosages also lead to higher levels of toxicity.

Another study conducted by Emory Eye Center in Atlanta found that patients who had used Elmiron for at least 16 years had a significantly increased risk of developing atypical maculopathy, a rare and painful eye disease. Researchers compared patients using Elmiron to a group of matched controls.

One woman from New York who took Elmiron for two years says that she developed a dangerous form of retinal damage. She is suing Janssen Pharmaceuticals, the company that makes the medication. Her claim is that the company knew of the risks and failed to warn her of them.

Fatal side effects of Elmiron

Taking medications such as Elmiron can cause fatal side effects. This drug is used to treat cystitis, which is a painful bladder problem. However, it has also been linked to serious vision problems. The long-term use of Elmiron can also lead to maculopathy, which is a type of eye disease that causes blindness.

In a recent study, researchers found that pentosan polysulfate sodium (Elmiron) can cause irreversible damage to the eyes. The paper was presented at the American Academy of Ophthalmology last year. Sadly, it was discovered that many patients who took the medication weren’t given enough information about the risk factors.

Affected patients could have grounds for legal action against Janssen Pharmaceuticals, the manufacturer of Elmiron. This company is a subsidiary of Johnson & Johnson, and has been sued for dangerous products. If you or someone you know has been harmed by the use of this medication, you may be eligible to join a mass tort lawsuit. This could protect you from any side effects and provide compensation.